Endothelium-derived relaxing factor and vascular grafting
van de Voorde, J.
International Journal of Artificial Organs 13(10): 647-650
1990
ISSN/ISBN: 0391-3988 PMID: 2254039 Document Number: 357671
Document emailed within 1 workday
Related Documents
Radomski, M.W.; Esplugues, J.V. 1988: Regulatory properties of vascular endothelium: focus on prostacyclin and endothelium-derived relaxing factor Methods and Findings in Experimental and Clinical Pharmacology 10(8): 537-541Moncada, S. 1986: Production of prostacyclin and endothelium-derived relaxing factor from endothelial cells Revista Clinica Espanola 179(6): 323-328
Allen, R.; Castro, L.; Arora, C.; Krakow, D.; Huang, S.; Platt, L. 1994: Endothelium-derived relaxing factor inhibition and the pressor response to norepinephrine in the pregnant rat Obstetrics and Gynecology 83(1): 92-96
Persson, P.B.; Baumann, J.E.; Ehmke, H.; Nafz, B.; Wittmann, U.; Kirchheim, H.R. 1992: Phasic and 24-h blood pressure control by endothelium-derived relaxing factor in conscious dogs American Journal of Physiology 262(5 Pt 2): H1395-H1400
Griffith, T.M.; Edwards, D.H. 1990: Myogenic autoregulation of flow may be inversely related to endothelium-derived relaxing factor activity American Journal of Physiology 258(4 Pt 2): H1171-H1180
Lot, T.Y. 1993: Guanidino succinic acid is not the endogenous source of endothelium-derived relaxing factor in the porcine isolated splenic artery Archives Internationales de Pharmacodynamie et de Therapie 323: 62-73
Mollace, V.; Salvemini, D.; Sessa, W.C.; Vane, J.R. 1991: Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols Journal of Pharmacology and Experimental Therapeutics 258(3): 820-823
Ignarro, L.J.; Buga, G.M.; Byrns, R.E.; Wood, K.S.; Chaudhuri, G. 1988: Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle Journal of Pharmacology and Experimental Therapeutics 246(1): 218-226
Fasehun, O.A.; Gross, S.S.; Rubin, L.E.; Jaffe, E.A.; Griffith, O.W.; Levi, R. 1990: L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor Journal of Pharmacology and Experimental Therapeutics 255(3): 1348-1353
Kaufmann, M.A.; Castelli, I.; Pargger, H.; Drop, L.J. 1995: Nitric oxide dose-response study in the isolated perfused rat kidney after inhibition of endothelium-derived relaxing factor synthesis: the role of serum albumin Journal of Pharmacology and Experimental Therapeutics 273(2): 855-862
Folger, W.H.; Lawson, D.; Wilcox, C.S.; Mehta, J.L. 1991: Response of rat thoracic aortic rings to thromboxane mimetic U-46,619: roles of endothelium-derived relaxing factor and thromboxane A2 release Journal of Pharmacology and Experimental Therapeutics 258(2): 669-675
Kuhn, M.; Otten, A.; Frölich, J.C.; Förstermann, U. 1991: Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells Journal of Pharmacology and Experimental Therapeutics 256(2): 677-682
Zhukova, A.V. 1999: The modulating effect of endothelial relaxing factor on the reactivity of the myocardium and of arterial vascular strips Fiziolohichnyi Zhurnal 45(1-2): 64-71
Lüscher, T.F.; Yang, Z.H.; Diederich, D.; Bühler, F.R. 1989: Endothelium-derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion Journal of Cardiovascular Pharmacology 14(Suppl 6): S63-S69
Zheng, X.F.; Pan, H.W.; Bian, R.L. 1987: Effects of tetrandrine on release of calcium-dependent endothelium-derived relaxant factor Zhongguo Yao Li Xue Bao 8(6): 525-529
Sumpio, B.E.; Widmann, M.D. 1990: Enhanced production of endothelium-derived contracting factor by endothelial cells subjected to pulsatile stretch Surgery 108(2): 277-281; Discussion: 281-282
Welt, K.; Schippel, K.; Mironov, V.A.; Mironov, A.A.; Alimov, G.A.; Bobrik, I.I.; Banin, V.V.; Karaganov, J.L. 1990: Vascular endothelium (review). I. General morphology. 2A: histogenesis of the vascular endothelium Gegenbaurs Morphologisches Jahrbuch 136(2): 163-199
Ionescu, C.; Berindan-Neagoe, I.; Burz, C.; Balacescu, O.; Balacescu, L.; Tudoran, O.; Asztalos, R.; Irimie, A. 2011: The clinical implications of platelet derived growth factor B, vascular endothelial growth factor and basic fibroblast growth factor in colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 16(2): 274-276
Viglietto, G.; Romano, A.; Maglione, D.; Rambaldi, M.; Paoletti, I.; Lago, C.T.; Califano, D.; Monaco, C.; Mineo, A.; Santelli, G.; Manzo, G.; Botti, G.; Chiappetta, G.; Persico, M.G. 1996: Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor Oncogene 13(3): 577-587
Jacobs, L.S.; Kester, M. 1993: Sphingolipids as mediators of effects of platelet-derived growth factor in vascular smooth muscle cells American Journal of Physiology 265(3 Pt 1): C740-C747